These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26831742)

  • 61. [Clinical trials for medicinal products. New European and national legal rules].
    Kreutz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical research. Effects of European legislation and current developments].
    Sudhop T; Enzmann H; Klar R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):375-6. PubMed ID: 19343281
    [No Abstract]   [Full Text] [Related]  

  • 63. [Regulatory aspects and medicolegal considerations regarding clinical drug trials].
    Cammarano A; De Dominicis E; Marella GL; Maurici M; Arcudi G
    Ig Sanita Pubbl; 2016; 72(2):145-56. PubMed ID: 27336959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [securPharm e. V. - a protective shield against falsified medicines].
    Bergen M; Hoferichter R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1255-1260. PubMed ID: 28929207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crossing borders: a critical review of the role of the European Court of Justice in EU health policy.
    Brooks E
    Health Policy; 2012 Apr; 105(1):33-7. PubMed ID: 22217862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does the new EU Regulation on clinical trials adequately protect vulnerable research participants?
    Gennet É; Andorno R; Elger B
    Health Policy; 2015 Jul; 119(7):925-31. PubMed ID: 25951954
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Public health policy in the European Community.
    Gouvras G
    Gesundheitswesen; 1997 Dec; 59(12):675-8. PubMed ID: 9483831
    [No Abstract]   [Full Text] [Related]  

  • 68. What is the role of ethics committees after Regulation (EU) 536/2014?
    Petrini C
    J Med Ethics; 2016 Mar; 42(3):186-8. PubMed ID: 26644425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimising SME Potential in Modern Healthcare Systems: Challenges, Opportunities and Policy Recommendations.
    Horgan D; van Kranen HJ; Morré SA
    Public Health Genomics; 2018; 21(1-2):1-17. PubMed ID: 30145589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The health society: importance of the new policy proposal by the EU Commission on health and consumer affairs.
    Kickbusch I
    Health Promot Int; 2005 Jun; 20(2):101-3. PubMed ID: 15937329
    [No Abstract]   [Full Text] [Related]  

  • 71. Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.
    Strech D; Littmann J
    Trials; 2012 Jul; 13():100. PubMed ID: 22747684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transparency battle resurfaces as EU trial revamp wraps up.
    Holmes D
    Nat Med; 2013 Jul; 19(7):797. PubMed ID: 23836204
    [No Abstract]   [Full Text] [Related]  

  • 76. An overview of European Union tobacco control legislation.
    Godfrey F
    Cent Eur J Public Health; 2000 May; 8(2):128-31. PubMed ID: 10857053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. EU countries 'must harmonise clinical trial regulations'.
    Saul H
    Eur J Cancer; 2003 Jan; 39(2):131. PubMed ID: 12608413
    [No Abstract]   [Full Text] [Related]  

  • 78. New EU clinical trials regulation.
    Westra AE; Bos W; Cohen AF
    BMJ; 2014 Jun; 348():g3710. PubMed ID: 24904029
    [No Abstract]   [Full Text] [Related]  

  • 79. [The electoral programs of political parties and Health: a handbook to guide].
    Quintaliani G; Rollino C; Sepe V; Di Iorio B
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 25083524
    [No Abstract]   [Full Text] [Related]  

  • 80. [Introduction. Principal measures inscribed in the law relating to the public health policy].
    Sante Publique; 2004 Dec; 16(4):703-11. PubMed ID: 15768765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.